InterCure Shares to Reverse Split on Monday, August 24th (NASDAQ:INCR)

InterCure Ltd. (NASDAQ:INCR) shares are set to reverse split on Monday, August 24th. The 1-5 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, August 23rd.

InterCure Stock Down 2.1%

NASDAQ:INCR opened at $0.93 on Thursday. The business’s fifty day moving average price is $0.97 and its 200 day moving average price is $0.89. The firm has a market capitalization of $50.85 million, a price-to-earnings ratio of 31.00 and a beta of 1.40. The company has a current ratio of 1.48, a quick ratio of 0.97 and a debt-to-equity ratio of 0.20. InterCure has a 1-year low of $0.68 and a 1-year high of $1.71.

Analyst Ratings Changes

Separately, Weiss Ratings raised InterCure from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

About InterCure

InterCure Ltd is an Israel-based medical cannabis company publicly listed on the Nasdaq Capital Market under the ticker INCR. The company’s operations span the entire value chain of medical cannabis, from the development of proprietary seed strains and controlled cultivation in a GMP-compliant facility to laboratory testing, cannabinoid extraction and formulation. InterCure serves licensed pharmacies and clinics within Israel and adheres to the regulatory framework established by the Israeli Ministry of Health.

Founded in 2013, InterCure has built a vertically integrated platform that supports both patient care and research initiatives.